AdaptHealth ( AHCO ) Q2 Revenue Falls 1%
AdaptHealth ( NASDAQ:AHCO ) , a major provider of home medical equipment and related services, issued its second quarter 2025 results on August 5, 2025. The company reported lower GAAP revenue and net income in Q2 2025 compared to both analyst expectations and the prior-year period.
AdaptHealth Corp. ( AHCO ) Lags Q2 Earnings and Revenue Estimates
AdaptHealth (AHCO) delivered earnings and revenue surprises of -93.33% and -0.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Insulet ( PODD ) Reports Next Week: Wall Street Expects Earnings Growth
Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AdaptHealth Corp. ( AHCO ) Expected to Beat Earnings Estimates: Should You Buy?
AdaptHealth (AHCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in AdaptHealth Stock?
Investors need to pay close attention to AHCO stock based on the movements in the options market lately.
Important Notice to Long-Term Shareholders of AdaptHealth Corp. ( NASDAQ: AHCO ) ; CorMedix Inc. ( NASDAQ: CRMD ) ; Napco Security Technologies, Inc. ( NASDAQ: NSSC ) ; and Virtu Financial Inc. ( NYSE: VIRT ) : Grabar Law Office is Investigating Claims on Your Behalf as Key Developments Occur in Underlying Class Actions - Cormedix ( NASDAQ:CRMD ) , AdaptHealth ( NASDAQ:AHCO )
PHILADELPHIA, July 02, 2025 ( GLOBE NEWSWIRE ) -- AdaptHealth Corp. AHCO Shareholder Class Action Stayed Pending Mediation: A federal securities fraud class action alleging that AdaptHealth Corp. AHCO, and certain of its officers failed to make proper disclosures to investors, has been stayed ...
Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Concentrix ( NASDAQ:CNXC ) , AdaptHealth ( NASDAQ:AHCO )
U.S. stock futures were higher this morning, with the Dow futures gaining over 100 points on Friday. Shares of Concentrix Corporation CNXC fell sharply in today's pre-market trading after the company posted mixed second-quarter results.
AdaptHealth Corp. ( AHCO ) Meets Q1 Earnings Estimates
AdaptHealth (AHCO) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS View
SYK's first-quarter results reflect strong segmental performance, along with a rise in operating margin.
DexCom Stock Rises Despite Q1 Earnings Miss & Lower Margins
DXCM's first-quarter 2025 earnings decline despite increasing sales. Its performance in 2025 is expected to be fueled by global growth in CGM adoption, strong Sensor sales and expansion into new markets.
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts. Shares rise in pre-market.
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y
Accuray reports solid fiscal third-quarter results, witnessing growth in Product & Services revenues and reduced operating expenses.
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline
Glaukos' first-quarter results showcase a strong uptick in revenues. However, continued operating loss remains a cause of concern.
CAH Q3 Earnings Beat Estimates, '25 EPS View Raised, Stock Gains
Cardinal Health's third-quarter fiscal 2025 results benefit from solid Medical and Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook
CNMD reports solid first-quarter results, driven by improving sales across both segments.
GE HealthCare Q1 Earnings & Sales Beat Estimates, Net Margin Rises
GEHC's first-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.
AdaptHealth ( AHCO ) Upgraded to Buy: Here's What You Should Know
AdaptHealth (AHCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AHCO or SYK: Which Is the Better Value Stock Right Now?
AHCO vs. SYK: Which Stock Is the Better Value Option?
Abbott ( ABT ) Q1 Earnings Beat Estimates
Abbott (ABT) delivered earnings and revenue surprises of 1.87% and 0.56%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Boston Scientific ( BSX ) Surges 6.8%: Is This an Indication of Further Gains?
Boston Scientific (BSX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Strength Seen in ResMed ( RMD ) : Can Its 3.8% Jump Turn into More Strength?
ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PHG Expands Enterprise Imaging in EU: Buy, Sell or Hold the Stock?
Philips expands cloud-based imaging in Europe, enhancing AI-driven workflows, collaboration and efficiency in radiology.
AHCO vs. ABT: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. ( AHCO Quick QuoteAHCO - ) and Abbott ( ABT Quick QuoteABT - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
Is AdaptHealth ( AHCO ) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Aurora Cannabis ( ACB ) Stock Outpacing Its Medical Peers This Year?
Here is how Aurora Cannabis Inc. (ACB) and AdaptHealth Corp. (AHCO) have performed compared to their sector so far this year.
Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings - AdaptHealth ( NASDAQ:AHCO ) , Bitdeer Technologies ( NASDAQ:BTDR )
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow traded up 0.46% to 43,661.51 while the NASDAQ fell 1.07% to 19,080.23. The S&P 500 also fell, dropping, 0.29% to 5,965.92. Consumer staples shares jumped by 1.3% on Tuesday.
Itron Posts Upbeat Results, Joins AdaptHealth, EverQuote, Goosehead Insurance And Other Big Stocks Moving Higher On Tuesday - Dream Finders Homes ( NYSE:DFH ) , AdaptHealth ( NASDAQ:AHCO )
U.S. stocks were mixed, with the Dow Jones gaining over 100 points on Tuesday. Shares of Itron, Inc. ITRI rose sharply during Tuesday's session after the company reported better-than-expected fourth-quarter financial results. Itron posted quarterly earnings of $1.35 per share, beating market ...
AdaptHealth Corp. ( AHCO ) Q4 Earnings and Revenues Surpass Estimates
AdaptHealth (AHCO) delivered earnings and revenue surprises of 34.48% and 3.27%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Down -16.54% in 4 Weeks, Here's Why AdaptHealth ( AHCO ) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for AdaptHealth (AHCO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
WAT Earnings & Sales Surpass Estimates in Q4, Shares Rise
WAT's fourth-quarter 2024 results reflect strong pharma growth and robust gains across all regions. However, forex headwinds hurt.
AHCO or ABT: Which Is the Better Value Stock Right Now?
AHCO vs. ABT: Which Stock Is the Better Value Option?
Should Value Investors Buy AdaptHealth ( AHCO ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Freshworks ( FRSH ) Q4 2024 Earnings Call Transcript
FRSH earnings call for the period ending December 31, 2024.
AHCO vs. HLN: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. ( AHCO Quick QuoteAHCO - ) and Haleon PLC Sponsored ADR ( HLN Quick QuoteHLN - ) . But which of these two companies is the best option for those looking for undervalued stocks?
Should Value Investors Buy AdaptHealth ( AHCO ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Implied Volatility Surging for AdaptHealth ( AHCO ) Stock Options
Investors need to pay close attention to AdaptHealth (AHCO) stock based on the movements in the options market lately.
These Analysts Lower Their Forecasts On AdaptHealth Following Weak Sales - AdaptHealth ( NASDAQ:AHCO )
AdaptHealth Corp. AHCO reported worse-than-expected third-quarter sales and revised its FY24 net revenue guidance on Tuesday. AdaptHealth reported quarterly sales of $805.86 million which missed the analyst consensus estimate of $809.30 million.
Why AdaptHealth Stock Got Thrashed on Tuesday
The company posted a triple whiff, coming in under pundit projections for revenue, profitability, and top-line guidance.
AdaptHealth Corp. ( AHCO ) Surpasses Q3 Earnings Estimates
AdaptHealth (AHCO) delivered earnings and revenue surprises of 5% and 0.35%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Zimmer Biomet ( ZBH ) Misses Q3 Earnings Estimates
Zimmer (ZBH) delivered earnings and revenue surprises of -0.57% and 1.12%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
AHCO or LZAGY: Which Is the Better Value Stock Right Now?
AHCO vs. LZAGY: Which Stock Is the Better Value Option?
Are Investors Undervaluing AdaptHealth ( AHCO ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Medical Stocks Lagging AdaptHealth ( AHCO ) This Year?
Here is how AdaptHealth Corp. (AHCO) and BellRing Brands (BRBR) have performed compared to their sector so far this year.
Do Options Traders Know Something About AdaptHealth ( AHCO ) Stock We Don't?
Investors need to pay close attention to AdaptHealth (AHCO) stock based on the movements in the options market lately.
Abbott Stock Gains on Q3 Earnings Beat, Margins Expand
ABT delivers a strong underlying base business performance in the third quarter of 2024.
Neogen Q1 Earnings Miss Estimates, Margins Crash
NEOG's Food Safety and Animal Safety businesses witness a year-over-year decrease in revenues in the first quarter of fiscal 2025.
AHCO vs. LZAGY: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. ( AHCO Quick QuoteAHCO - ) and Lonza Group Ag ( LZAGY Quick QuoteLZAGY - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer ...
Is AdaptHealth ( AHCO ) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AdaptHealth Corp. ( AHCO ) Beats Q2 Earnings and Revenue Estimates
AdaptHealth (AHCO) delivered earnings and revenue surprises of 10.53% and 0.45%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Myriad Genetics ( MYGN ) Expands in MRD Testing With New Collab
Myriad Genetics (MYGN) inks an agreement with Personalis to cross-license patent estates covering tumor-informed approaches to detect minimal residual disease. The idea is to broaden patient access to the benefits of MRD testing.
